These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8790251)

  • 21. [Quality of life and psychosocial factors during treatment with antihypertensive drugs. A comparison of captopril and quinapril in geriatric patients].
    Michalsen A; Wenzel RR; Mayer C; Broer M; Philipp T; Dobos GJ
    Herz; 2001 Nov; 26(7):468-76. PubMed ID: 11765480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of cardiovascular risk factors during antihypertensive treatment: a multicentre trial with quinapril.
    Manzato E; Capurso A; Crepaldi G
    J Int Med Res; 1993; 21(1):15-25. PubMed ID: 8319817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of quinapril versus atenolol: effects on blood pressure and cardiac mass after renal transplantation.
    Suwelack B; Gerhardt U; Hausberg M; Rahn KH; Hohage H
    Am J Cardiol; 2000 Sep; 86(5):583-5, A10. PubMed ID: 11009288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
    Ding YA; Chang SM; Chou TC
    J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A quinapril-hydrochlorothiazide combination in the treatment of essential arterial hypertension].
    Dominici P; Cosentina R
    Minerva Cardioangiol; 1997; 45(1-2):25-9. PubMed ID: 9213812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and safety of quinapril in the treatment of moderate to severe and severe hypertension: comparison to captopril.
    Frishman WH
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII26-31. PubMed ID: 2189618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Speed and duration of dose titration with the angiotensin converting enzyme inhibitor quinapril: relationship with efficacy in patients with moderate hypertension.
    Weir MR
    J Hum Hypertens; 1994 Sep; 8(9):725-30. PubMed ID: 7807504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combination antihypertensive therapy in patients with an increased risk profile].
    Bartens W; Nauck M; Wanner C
    Med Klin (Munich); 1996 Oct; 91(10):626-31. PubMed ID: 9019639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardioprotective effects of quinapril after myocardial infarction in hypertensive rats.
    Mori T; Nishimura H; Okabe M; Ueyama M; Kubota J; Kawamura K
    Eur J Pharmacol; 1998 May; 348(2-3):229-34. PubMed ID: 9652338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the efficacy and safety of quinapril with that of enalapril in the treatment of mild to moderate essential hypertension.
    Taylor SH
    Angiology; 1989 Apr; 40(4 Pt 2):382-8. PubMed ID: 2539763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of the clinical development of quinapril.
    Frank GJ
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII13-8. PubMed ID: 2189616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of quinapril versus nitrendipine on endothelial dysfunction in patients with systemic hypertension.
    Uehata A; Takase B; Nishioka T; Kitamura K; Akima T; Kurita A; Isojima K
    Am J Cardiol; 2001 Jun; 87(12):1414-6. PubMed ID: 11397368
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling.
    Nong Z; Stassen JM; Moons L; Collen D; Janssens S
    Circulation; 1996 Oct; 94(8):1941-7. PubMed ID: 8873672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinapril in the treatment of hypertension in primary care centers.
    Alcocer L; Novoa G; Sotres D
    Clin Ther; 1993; 15(6):1021-30. PubMed ID: 8111799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin converting enzyme inhibition corrects Na+/H+ exchanger overactivity in essential hypertension.
    Fortuño A; Tisaire J; López R; Bueno J; Díez J
    Am J Hypertens; 1997 Jan; 10(1):84-93. PubMed ID: 9008252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety profile of quinapril: is there a difference among ACE inhibitors?
    Canter D; Frank GJ; Knapp LE; McLain RW
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII39-42. PubMed ID: 2189620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats.
    Panizo A; Pardo J; Hernández M; Galindo MF; Cenarruzabeitia E; Díez J
    Am J Hypertens; 1995 Aug; 8(8):815-22. PubMed ID: 7576398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. Quinapril Investigator Group.
    Canter D; Frank GJ; Knapp LE; Phelps M; Quade M; Texter M
    J Hum Hypertens; 1994 Mar; 8(3):155-62. PubMed ID: 8006914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure.
    Riondino S; Pignatelli P; Pulcinelli FM; Lenti L; Di Veroli C; Marigliano V; Gazzaniga PP
    J Am Geriatr Soc; 1999 Aug; 47(8):943-7. PubMed ID: 10443854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of quinapril in the elderly patient.
    Schnaper HW
    Am J Hypertens; 1990 Nov; 3(11):278S-282S. PubMed ID: 2261146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.